Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer
Author:
Publisher
Genetics and Molecular Research
Subject
Genetics,Molecular Biology,General Medicine
Link
http://www.funpecrp.com.br/gmr/year2015/vol14-4/pdf/gmr7201.pdf
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. ABCF1/CXCL12/CXCR4 Enhances Glioblastoma Cell Proliferation, Migration, and Invasion by Activating the PI3K/AKT Signal Pathway;Developmental Neuroscience;2023-09-27
2. Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?;Frontiers in Molecular Biosciences;2023-01-09
3. Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies;International Journal of Molecular Sciences;2022-12-21
4. CXCL12, a potential modulator of tumor immune microenvironment (TIME) of bladder cancer: From a comprehensive analysis of TCGA database;Frontiers in Oncology;2022-11-07
5. CXCL12-CXCR4 AXIS: ITS ROLE AND THE DRUG INHIBITORS ON EACH TYPE OF CANCERS;WORLD CANCER RES J;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3